BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

ORBIMED ADVISORS LLC's Holding History (CIK: 0001055951)

Note: Option positions (PUT/CALL) are excluded.

Q2 2023
Shares 15,000,000 Value ($000) $9,265 Avg Close — Range —
Q1 2023
Shares 20,000,000 Value ($000) $12,853 Avg Close — Range —
Q4 2022
Shares 30,000,000 Value ($000) $12,600 Avg Close — Range —
Q3 2022
Shares 30,000,000 Value ($000) $12,509 Avg Close — Range —
Q2 2022
Shares 30,000,000 Value ($000) $12,150 Avg Close — Range —
Q1 2022
Shares 30,000,000 Value ($000) $14,416 Avg Close — Range —